Labcorp Holdings Inc., a key player in the healthcare sector, offers robust laboratory services essential for informed decision-making in medical settings. Investors should consider its steady performance metrics and overall market influence before making investment decisions.
The current fundamental rating of Labcorp Holdings Inc. reflects its stable financial health with a balanced mix of strengths and weaknesses.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 3 | |
Return on Assets | 5 | |
Debt to Equity | 1 | |
Price to Earnings | 2 | |
Price to Book | 3 |
Comparing the current and previous ratings demonstrates how the financial situation and performance metrics have evolved over time.
Date | Overall | DCF | ROE | ROA | Debt to Equity | PE | PB |
---|---|---|---|---|---|---|---|
2025-10-10 | 3 | 4 | 3 | 5 | 1 | 2 | 3 |
Previous | 0 | 4 | 3 | 5 | 1 | 2 | 3 |
The price targets provided by analysts illustrate forward-looking expectations for Labcorp Holdings Inc.'s market value.
High | Low | Median | Consensus |
---|---|---|---|
311 | 290 | 305 | 302.75 |
The sentiment data reveals the consensus among analysts regarding investment potential for Labcorp Holdings Inc.
Recommendation | Number | Distribution |
---|---|---|
Strong Buy | 0 | |
Buy | 26 | |
Hold | 9 | |
Sell | 0 | |
Strong Sell | 0 |
Labcorp Holdings Inc. exhibits a stable financial position with consistent ratings across key metrics, suggesting a reliable investment without significant growth but with potential for steady returns. Analysts' favorable sentiment and price targets indicate confidence in its market position. However, the debt-to-equity ratio remains a concern, necessitating careful consideration of financial strategies. Investors may find moderate gains appealing, alongside slight risks associated with market fluctuations and industry challenges. Overall, lab-based industry dynamics and technological advancements pose both opportunities and threats.